Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Medecine Sciences : M/S|July 3, 2020
[Iron and age-related macular degeneration: a new track]Yves Courtois, Jenny Youale, Francine Behar-Cohen, et al.Cells|March 19, 2020
From Rust to Quantum Biology: The Role of Iron in Retina PhysiopathologyEmilie Picard, Alejandra Daruich, Jenny Youale, et al.Scientific Reports|March 22, 2024
Phototoxicity of low doses of light and influence of the spectral composition on human RPE cellsAnaïs Françon, Kimberley Delaunay, Thara Jaworski, et al.Pharmaceutics|September 5, 2020
Transferrin Non-Viral Gene Therapy for Treatment of Retinal DegenerationKarine Bigot, Pauline Gondouin, Romain Bénard, et al.International Journal of Molecular Sciences|November 11, 2022
Neuroprotective Effects of Transferrin in Experimental Glaucoma ModelsJenny Youale, Karine Bigot, Bindu Kodati, et al.Journal of Proteome Research|February 5, 2026
Proteomic Signature in Men with Central Serous ChorioretinopathyChristophe Chambon, Emilie Picard, Marta Zola, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 4, 2021
Oral Ursodeoxycholic Acid Crosses the Blood Retinal Barrier in Patients with Retinal Detachment and Protects Against Retinal Degeneration in an Ex Vivo ModelAlejandra Daruich, Thara Jaworski, Hugues Henry, et al.Cell Death & Disease|October 6, 2025
Transferrin is a drug candidate for the treatment of dry age-related macular degeneration (AMD)Jenny Youale, Karine Bigot, Thara Jaworski, et al.Translational Research : the Journal of Laboratory and Clinical Medicine|May 30, 2024
Glyburide confers neuroprotection against age-related macular degeneration (AMD)Emilie Picard, Jenny Youale, Max J Hyman, et al.Pageof 1